{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T07:41:28Z","timestamp":1787816488209,"version":"build-2784847793"},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.anai.2018.02.018","type":"journal-article","created":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T12:35:33Z","timestamp":1519389333000},"page":"664-666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Xolair-induced recurrent anaphylaxis through sensitization to the excipient polysorbate"],"prefix":"10.1016","volume":"120","author":[{"given":"Emilie","family":"Perino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Freymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Devouassoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Nicolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Berard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2018.02.018_bib0010","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.jaci.2017.07.013","article-title":"Anaphylaxis associated with omalizumab administration: risk factors and patient characteristics","volume":"140","author":"Lieberman","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2018.02.018_bib0015","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1208\/s12248-015-9821-x","article-title":"Evaluation of IgE antibodies to omalizumab (Xolair\u00ae) and their potential correlation to anaphylaxis","volume":"18","author":"Baker","year":"2016","journal-title":"AAPS J"},{"key":"10.1016\/j.anai.2018.02.018_bib0020","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/cod.12084","article-title":"A case of anaphylaxis caused by polyethylene glycol analogues","volume":"69","author":"Yamasuji","year":"2013","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.anai.2018.02.018_bib0025","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2500\/aap.2007.28.3003","article-title":"Anaphylactoid reactions in two patients after omalizumab administration after successful long-term therapy","volume":"28","author":"Price","year":"2007","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.anai.2018.02.018_bib0030","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.anai.2015.04.014","article-title":"Anaphylaxis and serum sickness in patients receiving omalizumab: reviewing the data in light of clinical experience","volume":"115","author":"Harrison","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2018.02.018_bib0035","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1710-1492-6-32","article-title":"Omalizumab: practical considerations regarding the risk of anaphylaxis","volume":"6","author":"Kim","year":"2010","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.anai.2018.02.018_bib0040","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s12016-015-8490-y","article-title":"Off-label uses of omalizumab","volume":"50","author":"El-Qutob","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.anai.2018.02.018_bib0045","doi-asserted-by":"crossref","first-page":"394","DOI":"10.18176\/jiaci.0109","article-title":"Anaphylaxis due to the excipient polysorbate 80","volume":"26","author":"Palacios Casta\u00f1o","year":"2016","journal-title":"J Invest Allergol Clin Immunol"},{"key":"10.1016\/j.anai.2018.02.018_bib0050","first-page":"61","article-title":"Polyethylene glycols (PEG) and related structures: overlooked allergens in the perioperative setting","volume":"4","author":"Wenande","year":"2015","journal-title":"Case Rep"},{"key":"10.1016\/j.anai.2018.02.018_bib0055","first-page":"1890","article-title":"Comparative study on pseudoanaphylactoid reactions induced by medicinal Tween 80 and injectable Tween 80","volume":"37","author":"Wang","year":"2012","journal-title":"Zhongguo Zhong Yao Za Zhi"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120618301455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120618301455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:19:57Z","timestamp":1761052797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120618301455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S1081120618301455"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2018.02.018","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Xolair-induced recurrent anaphylaxis through sensitization to the excipient polysorbate","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2018.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}